Podcasts about Diatribe

In this week's episode, Tulsi Gabbard is in a cult worse than conservatism, Dusty Deevers rides off sadly into the sunset with tumbleweed rolling past, and we'll once again learn the importance of not f**king.---To make a per episode donation at Patreon.com, click here: http://www.patreon.com/ScathingAtheistTo buy our book, click here: https://www.amazon.com/Outbreak-Crisis-Religion-Ruined-Pandemic/dp/B08L2HSVS8/If you see a news story you think we might be interested in, you can send it here: scathingnews@gmail.comTo check out our sister show, The Skepticrat, click here: https://audioboom.com/channel/the-skepticratTo check out our sister show's hot friend, God Awful Movies, click here: https://audioboom.com/channel/god-awful-moviesTo check out our half-sister show, Citation Needed, click here: http://citationpod.com/To check out our sister show's sister show, D and D minus, click here: https://danddminus.libsyn.com/Report instances of harassment or abuse connected to this show to the Creator Accountability Network here: https://creatoraccountabilitynetwork.org/---Guest Links:Get tickets to see Noah in Cincinnati: https://www.sethandrews.com/cincinnatiLearn more about the Ark Park protest here: https://www.facebook.com/events/ark-encounter/10th-anniversary-ark-encounter-protest/1591721388785519/Get your tickets to BAHACon here: https://bahacon.com/---Headlines:Court doesn't care about religious freedom when it isn't a Christian (from the Diatribe): https://www.nbcnews.com/politics/supreme-court/supreme-court-rules-rastafarian-man-religious-rights-claim-prison-offi-rcna252594WaPo exposes the degree to which Tulsi Gabbard is all culted up: https://www.washingtonpost.com/investigations/2026/06/21/tulsi-gabbard-her-guru-mysterious-messages-that-helped-shape-her-political-career/Trump Admin Rebrands Frozen Embryos As 'Children Who Already Exist': https://www.wonkette.com/p/trump-admin-rebrands-frozen-embryosPope Leo Popularity Plummets With Republican Catholics: https://www.newsweek.com/pope-leo-popularity-republican-catholics-12095241DOJ says it will investigate MLB for issuing warning to players after anti-Pride protest: https://www.friendlyatheist.com/p/mlb-warns-san-francisco-giants-playershttps://www.theguardian.com/sport/2026/jun/19/mlb-investigation-department-of-justice-pride-hats-religious-discriminationRob Schneider offers to pay the fines: https://www.kron4.com/news/bay-area/maga-comedian-rob-schneider-offers-to-pay-fines-for-giants-players-over-pride-protest/Also Ted Nugent joined them: https://rockcelebrities.net/ted-nugent-joins-baseball-players-pride-jersey-fight-calls-rainbow-flag-evil/Christian Nationalist Pastor Dusty Deevers Loses Reelection Bid: https://www.peoplefor.org/rightwingwatch/right-wing-boost-christian-nationalist-pastor-dusty-deevers-loses-reelection-bidHis replacement: https://pmc.ncbi.nlm.nih.gov/articles/PMC6179563/Who is the head physician for this: https://prclawton.com/

Drew has seen the England National Team in the World Cup and is adopting them for the 3D for the next month or so...Well, adopting "parts" of it...?

It's In The News, where we bring you the top diabetes stories and headlines happening now. Top stories this week: Dexcom shares details of its next generation CGM, T1D and GLP-1 studies, weight loss management on GLP-1 medications updates, all-in-one CGM and pump, and more! Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Episode transcript: XX Dexcom announces some features of it's next generation CGM – the G8. We've been talking about this with CEO Jake Leach for a while now – it will be a 50% smaller with what they're calling advanced sensing capabilities. According to Leach, G8 will adapt to the physiologic variability of each user. It has additional technology built in, based on a new silicon chip design and algorithm. 15 day wear is now the baseline for all Dexcom sensors moving forward. At launch the G8 will only measure glucose but the plan is for a multi-analyte version to follow. That would measure ketones and potassium. Ketones we know – but potassium is very important for people with kidney and possible for people taking some diabetes meds. It's an interesting space to watch.. btw, analyte is just a medical word for the specific thing you're measuring – the target of the test you're running. we're going to hear that word a lot I think..   Looks like an FDA submission for the G8 next year.. with an outside the US launch the following year. https://www.drugdeliverybusiness.com/dexcom-unveils-next-gen-g8-cgm/ XX Glucotrack has submitted its implantable continuous blood glucose monitor (CBGM) for FDA IDE, that's investigational device exemption and would enable the company to initiate a U.S. clinical study for the fully implantable technology. Rutherford, New Jersey-based Glucotrack's device features no on-body external component. The company aims to offer it for three years of continuous, accurate blood glucose monitoring for a more convenient, less intrusive solution. Unlike traditional CGMs that measure glucose in interstitial fluid, the CBGM measures glucose levels directly from the blood. The implant goes five centimeters within the subclavian vein. Glucotrack's active implantable device has a small battery and some electronics that go just under the skin in the pectoral region. The location of the implant is not in a major vessel, but the implant can measure real-time glucose levels as pulsatile blood flows over the tip of the sensor. https://www.drugdeliverybusiness.com/glucotrack-submits-long-term-implantable-cbgm-fda-ide/ XX PharmaSens today announced the publication of data from the first clinical study evaluating its all-in-one insulin patch pump offering. The all-in-one pump pairs the Niaa Essential insulin patch pump with the SynerG continuous glucose monitor (CGM) sensor developed by Pacific Diabetes Technologies. However, this system would be one device that features both the pump and CGM technology.   PharmaSens and SiBionics also have a collaboration aimed at developing the all-in-one solution. They are jointly developing the next-generation Niia insulin patch pump with a SiBionics CGM. PharmaSens expects a second feasibility study in the second quarter to evaluate the next-generation pump with SiBionics' CGM.   PharmaSens says the clinical feasibility study of Niia demonstrated for the first time ever that the combined offering is, in fact, feasible. It believes its device addresses the need for alternatives to multi-device diabetes management. systems.   Aggregated MARD for the investigational device came in at 11.6%. A MARD target of less than 10% is considered ideal for CGM devices, but PharmaSens said that, in the context of the early feasibility study, the results were encouraging and provide evidence supporting the development of an all-in-one system. https://www.drugdeliverybusiness.com/pharmasens-efs-insulin-patch-pump-cgm/ XX   XX ViCentra launches the newest version of the Kaleido pump system in Europe. This is that small colorful pump, with Diabeloops algorithm and the Dexcom G7. It'll be in Germany and the Netherlands later this summer. https://hellokaleido.com/vicentra-announces-commercial-launch-of-new-smartphone-controlled-kaleido-automated-insulin-delivery-patch-pump-system/--   XX Diabeloop just got CE Mark approval for DBLG2 integrations – it's latest AID platform the company has kicked off the gradual European launch of the technology. It currently offers DBLG2 as a smartphone application on Android, with iOS integration coming soon. As you just heard, it's integrated with kaleido and the company says it plans to make additional configuration for DBLG2 with alternative pumps "available soon." Running on a user's smartphone, DBLG2 works as a self-learning algorithm. It continuously analyzes glucose data, calculates insulin needs in real time and automatically adjusts delivery. https://www.drugdeliverybusiness.com/diabeloop-fda-next-gen-algorithm-g7/   XX Among adults with type 1 diabetes (T1D), the initiation of GLP-1-based therapy was associated with a lower risk for all-cause death, several cardiovascular outcomes, all-cause hospitalisations, and hypoglycaemia, without a higher risk for diabetic ketoacidosis.   METHODOLOGY: Researchers in Greece conducted a retrospective cohort study utilising real-world data from a global health research network to evaluate the association between GLP-1-based therapy and cardiovascular and renal outcomes in adults with T1D. A total of 4088 patients receiving GLP-1-based therapies (median age, 43 years; 34.3% men) were propensity score matched with an equal number of patients not receiving the treatment. The risk for hypoglycaemia was lower with GLP-1-based therapy (hazard ratio, 0.72; P = .021); however, the risk for diabetic ketoacidosis did not differ significantly between the two groups. https://www.medscape.com/viewarticle/glp-1-drugs-tied-cardiovascular-benefits-t1d-2026a1000fbx   XX Eli Lilly and Company (NYSE: LLY) today announced detailed results from two late-phase trials showing that people with obesity maintained their weight loss long term with either Foundayo or lower-dose Zepbound after switching from higher doses of injectable incretin therapy. The findings from SURMOUNT-MAINTAIN and ATTAIN-MAINTAIN, were presented at the 33rd European Congress on Obesity (ECO) and published in The Lancet and Nature Medicine, respectively.   "Weight regain remains one of the biggest challenges in obesity care, and is often the result of treatment interruptions that cause biology to work against patients, undoing the progress they've made," said Louis J. Aronne, M.D., FACP, DABOM, founder and Chair Emeritus of the American Board of Obesity Medicine, former president of The Obesity Society, Fellow of the American College of Physicians, world-renowned obesity specialist and Lilly consultant. "These medicines can be used for long-term maintenance today, and results from SURMOUNT-MAINTAIN and ATTAIN-MAINTAIN provide additional evidence of their potential when switching from higher doses of injectable incretin therapy." https://investor.lilly.com/news-releases/news-release-details/lillys-foundayo-and-lower-dose-zepbound-helped-people-maintain XX Scientists in Sweden have developed a more reliable way to create insulin-producing cells from human stem cells. These lab-grown cells not only respond strongly to glucose but were also able to restore blood sugar control when transplanted into diabetic mice. When transplanted into diabetic mice, the cells gradually restored the animals' ability to regulate blood sugar. Long way to go, as we say with most of these mice studies. https://www.sciencedaily.com/releases/2026/05/260505234620.htm XX Interesting look at how the body controls sugar storage – apparently this finding challenges long-standing biology concepts and could open new directions for disease treatment. Published in Nature, the study describes a potential method for directly reducing glycogen, the stored form of sugar in the body. These scientists discovered that glycogen can be directly regulated by ubiquitin, a protein best known for marking damaged proteins for recycling or removal. The study is the first to show that ubiquitin can regulate glycogen in humans, overturning more than 50 years of scientific understanding. Excess glycogen is also associated with more common health problems, including diabetes, obesity, liver disease, and heart disease.       https://scitechdaily.com/scientists-just-rewrote-biology-hidden-mechanism-could-transform-diabetes-treatment/ XX A new Oklahoma law will give parents the option to have their children screened for Type 1 Diabetes.   The measure passed with overwhelming bipartisan support in the Legislature and takes effect Nov 1. Oklahoma consistently ranks among the states with the highest rates of diabetes and diabetes-related deaths. The law gives parents access to antibody testing that can detect risk years before symptoms develop, helping families take preventive action and avoid emergency room visits. https://journalrecord.com/2026/05/11/oklahoma-law-expands-access-type-1-diabetes-screening/ XX More to come including a new study trying to figure out why some people are more likely to develop diabetes, a look at cannabis and preventing metabolic disorders, and XX   A National Institutes of Health (NIH)-funded study has identified key differences in human pancreatic islet cells that may help explain why some people are more likely to develop diabetes. Researchers found that the mix of hormone-producing cells in the pancreas varies widely from person to person, and that variation plays a central role in how the body regulates blood sugar. The study involved a deep dive into islet cell function that is linked to donor traits associated with observable characteristics, or phenotype, such as sex, race and ethnicity, as well as genetic information, or genotype, including predicted ancestry and genetic risk for both type 1 and type 2 diabetes. The findings highlight that islet cell composition, rather than the physical size and shape of islets, is a key factor in regulating hormone release. The team found that the makeup of pancreatic islets plays a major role in how effectively they release insulin and glucagon — key hormones that regulate blood glucose. Islets with a higher proportion of insulin-producing beta cells showed stronger insulin secretion in response to various stimuli, while higher levels of alpha and delta cells were generally linked to reduced insulin output. In addition, the researchers found that islet hormone secretion is affected by donor traits, such as sex, race and ethnicity and their genetic makeup, including ancestry predicted from genetic testing and genetic risk for type 2 diabetes. Combined, the findings of the study have significant implications for understanding the factors that may predispose people to diabetes. "This study is the tip of the iceberg," said Dr. Evans-Molina. "We hope this dataset becomes useful to the entire diabetes research community and that researchers use it to answer questions about the genotype-phenotype correlation within these data."   https://www.nih.gov/news-events/news-releases/nih-funded-study-maps-human-pancreatic-islet-cells-offering-new-clues-diabetes-risk XX XX XX Research published recently in JAMA Network Open offers illuminating evidence suggesting there is a positive association between GLP-1 agonists—drugs commonly used to treat obesity and diabetes—and better outcomes among breast cancer patients.   "This study suggests that GLP-1 drugs may offer protective benefits potentially improving survival and recurrence risk in some female patients with breast cancer – whether this is related to weight control, improve cardiovascular health or other mechanisms remains to be studied," said study senior author Bernard F. Fuemmeler, Ph.D., MPH, associate director for population sciences and the Gordon D. Ginder, M.D., Chair in Cancer Research at VCU Massey Comprehensive Cancer Center.   Breast cancer patients who are also obese or have type 2 diabetes experience more aggressive cancer growth and worse outcomes. Prior studies have shown that weight loss treatment and surgery following a breast cancer diagnosis are associated with improved heart health and increased survival.   What are GLP-1 drugs? Glucagon-like peptide-1 receptor agonists (GLP-1 RAs). Approved to treat type 2 diabetes in 2005 and weight management in 2021. Impacts on breast cancer survival and recurrence are still unclear. Since 2020, the use of these drugs has increased dramatically, where approximately 12% of Americans have used GLP-1s for weight loss, according to a RAND report.   The research findings Through a retrospective cohort study examining the electronic health records of more than 840,000 breast cancer patients who were diagnosed between 2006 and 2023, the results suggest there is a potential link between GLP-1 RAs and improved outcomes among breast cancer patients who are also obese or have type 2 diabetes.   GLP-1 RA use was associated with an overall lower risk of death from any cause over a 10-year follow-up period among breast cancer patients. Additionally, breast cancer survivors who used GLP1-RAs for diabetes or obesity had a significantly lower risk of their cancer returning over 10 years following their initial treatment.   "Our findings align with emerging preclinical research and contribute to a growing body of literature related to GLP-1 RA use in oncology settings," said study lead author Kristina L. Tatum, PsyD, MS, of the VCU School of Public Health.   What's next? Further studies are needed to understand the biological mechanisms, if any, between GLP-1 RAs and breast cancer outcomes. The research team intends to further evaluate these correlations through randomized clinical trials.   "Our study underscores the potential of GLP-1 RAs as an adjunct strategy for improving cancer-related outcomes among patients with breast cancer, although clinical trials are needed to inform effective therapeutic approaches and clinical decision making," Fuemmeler said. https://www.oncology-central.com/could-glp-1-receptor-agonists-improve-outcomes-for-breast-cancer-patients-with-obesity-or-with-type-2-diabetes/ XX Researchers at UC Riverside gave cannabis to obese mice and found that not only did the rodents lose weight, but when given a concentrated cannabis oil, the mice also saw striking benefits in their metabolic function. DiPatrizio said his team studied the issue to better understand why cannabis users show significant reductions in weight and risk for diabetes compared with nonusers. "We would think that chronic cannabis users would be eating more and weigh more, but it's just the opposite," DiPatrizio said. Scientists are increasingly examining the possibility that cannabis compounds could fight obesity or metabolic disorders like diabetes. Cannabinoids interact with the body's endocannabinoid system, which partially controls nearly every aspect of our physiology, including metabolism and appetite. That creates the possibility that targeting this widespread system could unlock new therapies for these conditions. https://www.sfgate.com/cannabis/article/cannabis-weight-loss-california-study-22255328.php XX A new campaign launched by diaTribe and Genentech aims to empower and educate people about diabetes-related eye disease. Here's what you can do today to protect your eye health. To help address these barriers, diaTribe and Genentech partnered to launch All Eyes on DME, a new campaign that aims to spread awareness and educate people at-risk for or living with diabetes-related eye conditions like DME. Also partnering in the campaign is actor and comedian Damon Wayans, who wanted to share his journey (and, of course, a joke or two) with type 2 diabetes to open up the conversation about what is often a stigmatized or less talked about topic: eye health and diabetes.   One of these important conversations happened recently at the All Eyes on DME launch in New York City, where Wayans joined a panel of experts, advocates, and people living with DME to talk about diabetes-related eye disease and how to help prevent it. https://www.alleyesondme.com/dme-in-the-spotlight.html https://diatribe.org/diabetes-complications/all-eyes-dme-new-campaign-spotlights-eye-health-and-diabetes

Remembering Gabriel Rosenstock - Schiaparelli at the V&A - Diatribe Stage at New Music Dublin - Stephen Sexton at the Granard Booktown Festival

Soldi freschi per il #milan dai prestiti in giro per mezza Europa. Chi li gestirà? #tare o #furlani? #calciomercato #acmilanDiventa un supporter di questo podcast: https://www.spreaker.com/podcast/radio-rossonera--2355694/support.

92Noon! Charch - CG Recap - Darnold

92Noon! Charch - CG Recap - DarnoldSee omnystudio.com/listener for privacy information.

Dave and Paul cover coaching changes across Cochise County, review the MLK Classic, and discuss region play starting for all winter sports. The episode also includes Quizzly for Pizzly and Dave’s Diatribe. Presented by Synergy HomeCare.Support the show: https://www.myheraldreview.com/site/forms/subscription_services/See omnystudio.com/listener for privacy information.

Buckle up, metalheads! We're kicking off 2026 with a lethal dose of tequila, whiskey, and the heaviest tracks hitting the scene. In this episode, we're diving deep into the "frozen prairie" deathcore of Canada's From Beneath, the haunting melodies of Missouri's Generation Z, and the anthemic fury of Texas warriors Lockjaw.But it's not just about the music—it's about the chaos. We're laying out our (highly questionable) New Year's Resolutions, ranging from "Circle Pits of Politeness" to "Taco Bell soul-searching." Whether we're haunting the aisles of Hot Topic or letting crowd-surfers hit the floor "Drowning Pool style," we're bringing the energy you need to survive the mosh pit.

It's another round of the 3DDrew walks you through 2025 and introduces 2026 with his beloved Manchester United- in a fight for Europe with Leeds United waiting early Sunday morning at Elland Road 

Drew Dickinson returns for another round of the 3D- looking at Manchester United and, also, looking at England as they get ready for the World Cup Draw Friday

Jacob Rees-Mogg gatecrashes Labour Party conferenceJacob Rees-Mogg gatecrashes Labour Party conferenceSir Keir Starmer takes centre stage at the Labour conference as his leadership faces pressure from Andy Burnham's party coup and the growing threat of Nigel Farage's Reform. During his speech, the Prime Minister admitted that Labour had “patronised” working people on immigration, promising to ‘build a Britain for all' as minister waved flags in the audience.Camilla and Tim react to ‘slippery' Starmer's performance after he announced plans to scrap Blair's target of getting 50% young people in university, a major overhaul of the NHS and made claims that Nigel Farage “doesn't like Britain”, calling the Reform leader a “snake oil merchant”.Camilla also caught up with Secretary of State for Health and Social Care Wes Streeting after he called for the return of his friend and colleague Angela Rayner during his speech.And Tim Stanley speaks to Labour donor energy boss Dale Vince about his first impressions of the conference, the future of his friend Corbyn's Your Party, Gaza and the rise of Reform.Producer: Georgia CoanSenior Producer: John CadiganVideo Editors: Will Walters and Andy MackenzieExtra production: James EnglandExecutive Producer: Charlotte Seligman Watch:Jacob Rees-Mogg gatecrashes Labour Party conference Hosted on Acast. See acast.com/privacy for more information.

Hey Diabuddy thank you for listening to show, send me some positive vibes with your favorite part of this episode.You may have heard of Adam Brown's popular article from Diatribe, “42 Factors That Affect Blood Glucose”—a game-changing guide for anyone living with Diabetes. But how do those 42 factors show up in real life? And are there other variables we should be paying attention to?In part 3, I compare Adam's list and my list of dosing strategies and the medications that affect blood glucose. DiaTribe - The 42 Factors That Affect Blood GlucoseBright Spots & Landmines: By Adam BrownKey Takeaways:Insulin Timing Pre-BolusingExpired or Bad InsulinInaccurate CGM ReadingsInsulin QuantityAbout the HostI'm Coach Ken Kniss, founder of Simplifying Life With Diabetes and host of The Healthy Diabetic Podcast. I help people living with diabetes feel confident, informed, and in control—without the hesitation and distrust in their diabetes decisions. 

Drew breaks down the week in everything United...His beloved side signs their man in Benjamin Sesko and welcomes back an old friend for a friendly- that may or may not be...

Drew sets up the table on his beloved United as they prep for the Summer Series appearance in Atlanta this weekend...The ins, the outs, and the what-to-expect for the 2025 season in England... 

EXCLU PODCAST – Aujourd'hui, autour d'Olivier Truchot : Flora Ghebali, Mourad Boudjellal et Didier Giraud.

Hey Diabuddy thank you for listening to show, send me some positive vibes with your favorite part of this episode.You may have heard of Adam Brown's popular article from Diatribe, “42 Factors That Affect Blood Glucose”—a game-changing guide for anyone living with Diabetes. But how do those 42 factors show up in real life? And are there other variables we should be paying attention to?In part 2, I dive into Adam Brown's list and compare it to the 42 factors I've personally identified through years of living with Type 1 Diabetes and coaching. We'll explore the overlaps, differences, and surprising variables that are often overlooked. Whether you're newly diagnosed or a seasoned pro, this episode will give you a fresh perspective on just how many things can influence blood sugar—and how you can stay ahead of them.DiaTribe - The 42 Factors That Affect Blood GlucoseBright Spots & Landmines: By Adam BrownCoach Ken's Resources:Website: www.simplifyingdiabetes.comNewsletter Sign Up"More Than A1C" - My Signature Coaching ProgramThe Diabetes Nutrition Master CourseThe 5-Pillars Of Diabetes Success WorksheetSet Up a Free Call...Apparel StoreSupport & Donate To The PodcastThe T1D Exchange Registry is a research study, conducted over time, for individuals with type 1 diabetes and their supporters. Participants volunteer to provide their data for Diabetes research. Once enrolled, Registry participants have the opportunity to sign up for other studies on various topics related to type 1 diabetes.You can make an impact on the future of Diabetes now! Fill out an online  survey and gain access to tons of new research and the online portal. It only takes 10-15 minutes.Have a question, send me a DM or email. I'd love to connect and answer any questions you have.You can find the show  on any platform you listen to your podcasts!Don't forget to click on that subscribe button and leave a 5-star review, so you're notified when new episode drop every week.Questions about diabetes, don't hesitate to reach out:Instagram: @CoachK3NInstagram: @thehealthydiabeticpodFacebook: @Simplifying Life With DiabetesEmail: ken@simplifyingdiabetes.comPodcast Disclaimer: Nothing that you hSupport the show

In this episode, WYCE station manager Phil Tower speaks with Wardell Frazier, Jr., Executive Director of The Diatribe, and J-Lin Tamminga, Director of Education at The Diatribe.Both Wardell and J-Lin spoke about the Diatribe Vision: Creating art that is informative because we know that some of the most complex topics can be digested easier through an artistic lens, and that some of the most complex verbiage can be redivided through the creative gaze; words like racism, justice, and even liberation.A critical and exciting piece of the future for The Diatribe is The Emory Arts & Culture Hub.  In a real sense, it is “a dream home” for the Diatribe leadership.With the Emory Arts & Culture Hub, the Diatribe plans a new model for redevelopment that they hope will serve as an example for inclusive community and economic growth, potentially influencing more of this type of work in communities across the country.  ONLINE:  The Diatribe 

“Life is something that happens for you, not to you.  I did something that makes people present their absolute best selves to me every single day.  I did that.  And anyone can simply choose to do it for themselves.” -  Jim CarreyPlease visit MaverickMatthews.com and consider becoming a subscriber to support the show.Thanks for listening! New Ideas:Every quarter a Corporate CEO should be plucked from their home, along with their family, and forced to trade places and live the rest of their lives in the poorest home of their lowest paid employee.  Each Quarter a new forced switch.  This is how we fix the Corporate American Problem.

Welcome back to “What I Know Now,” a podcast by The Delta Project dedicated to honest, raw conversations about life inside—and beyond—the juvenile justice system. In today's episode, co-hosts Bilal and Cole Williams are joined by Wardell Frazier Jr., a decorated community leader, nonprofit founder, and executive director of The Diatribe. Wardell shares his powerful journey from growing up in Grand Rapids, through decades of hands-on nonprofit work, to building impactful programs for youth. Together, they dig into the power of authentic servant leadership, the healing and transformative force of arts, and how uplifting youth voices can change lives—and even reshape communities. Plus, Wardell opens up about his personal story, the influence of his father, and the legacy he hopes to leave for his own children. Tune in for an inspiring conversation rooted in love, resilience, and the unshakeable belief that young people deserve to be heard.

Hey Diabuddy thank you for listening to show, send me some positive vibes with your favorite part of this episode.You may have heard of Adam Brown's popular article from Diatribe, “42 Factors That Affect Blood Glucose”—a game-changing guide for anyone living with diabetes. But how do those 42 factors actually show up in real life? And are there other variables we should be paying attention to?In this episode, I dive into Adam Brown's list and compare it to the 42 factors I've personally identified through years of living with Type 1 Diabetes and coaching others. We'll explore the overlaps, the differences, and the surprising variables that often get overlooked. Whether you're newly diagnosed or a seasoned pro, this episode will give you a fresh perspective on just how many things can influence blood sugar—and how you can stay ahead of them.DiaTribe - The 42 Factors That Affect Blood GlucoseBright Spots & Landmines: By Adam BrownCoach Ken's Resources:Website: www.simplifyingdiabetes.comNewsletter Sign Up"More Than A1C" - My Signature Coaching ProgramThe Diabetes Nutrition Master CourseThe 5-Pillars Of Diabetes Success WorksheetSet Up a Free Call...Apparel StoreSupport & Donate To The PodcastThe T1D Exchange Registry is a research study, conducted over time, for individuals with type 1 diabetes and their supporters. Participants volunteer to provide their data for Diabetes research. Once enrolled, Registry participants have the opportunity to sign up for other studies on various topics related to type 1 diabetes.You can make an impact on the future of Diabetes now! Fill out an online  survey and gain access to tons of new research and the online portal. It only takes 10-15 minutes.Have a question, send me a DM or email. I'd love to connect and answer any questions you have.You can find the show  on any platform you listen to your podcasts!Don't forget to click on that subscribe button and leave a 5-star review, so you're notified when new episode drop every week.Questions about diabetes, don't hesitate to reach out:Instagram: @CoachK3NInstagram: @thehealthydiabeticpodFacebook: @Simplifying Life With DiabetesEmail: ken@simplifyingdiabetes.comPodcast DiscSupport the show

In this Dialogue episode of The Synopsis, we give an update on Airbnb after 1Q25 earnings. Check out our written business updates for $ABNB below!  Airbnb 1Q25 Business Update ~*~ For full access to all of our updates and in-depth research reports, including our CoStar Group and Evolution Extensive Research Reports, become a Speedwell Member here. Please reach out to info@speedwellresearch.com if you need help getting us to become an approved research vendor in order to expense it. -*-*-*-*-*-*-*-*-*-*-*-*-*-*- Show Notes (0:00) Intro (1:49) — Airbnb High Level Update  (6:40) — Diatribe on Sell-Side Analyst Q&A (9:00) — Airbnb Growth Slowdown and Macro (22:30) — Airbnb's New Businesses (29:30) — Valuation, Mature Margin Defense -*-*-*-*-*-*-*-*-*-*-*-*-*-*- For full access to all of our updates and in-depth research reports, become a Speedwell Member here. Please reach out to info@speedwellresearch.com if you need help getting us to become an approved research vendor in order to expense it. *-*-*- Follow Us: Twitter: @Speedwell_LLC Threads: @speedwell_research Email us at info@speedwellresearch.com for any questions, comments, or feedback. -*-*-*-*-*-*-*-*-*-*- Disclaimer Nothing in this podcast is investment advice nor should be construed as such. Contributors to the podcast may own securities discussed. Furthermore, accounts contributors advise on may also have positions in companies discussed. At the time of publication, one or more contributors to this report has a position in ABNB. Furthermore, accounts one or more contributors advise on may also have a position in ABNB. This may change without notice. Please see our full disclaimers here:  https://speedwellresearch.com/disclaimer/

Christian ; Follower of GOD Servant of CHRIST        Decorated Combat VeteranCorporate; U.S. Marine Corps Urban Warfare Instrictor;       S.R.T. Commander Active Shooter Response Team Law Enforcement Los Angeles Police (L.A.P.D.) Police Officer / Fugitive RecoveryF.B.I. Instructor N.R.A Instructor Competition Shooter; Multi Time State Rifle Pistol Champion Hunting; Life Long Hunter Proffessional Hunter and Guide Private Security Contractor; Several Agencies,  Current. GOD Provides / JESUS SavesPatreon https://bit.ly/3jcLDuZBecome a supporter of this podcast: https://www.spreaker.com/podcast/gunfighter-life-survival-guns-tactical-hunting--4187306/support.

See omnystudio.com/listener for privacy information.

See omnystudio.com/listener for privacy information.

The Dow falls as tech stocks fall after President Trump slams U.S. Federal Reserve Chairman Jerome Powell for failing to cut interest rates. The dollar falls to a three-year low on tariff concerns. Chinese battery maker CATL unveils new cells, claiming faster charging times and longer range than rival BYD. Also in autos news, Tesla shares plunge 6 per cent ahead of earnings due out later today with one analyst calling the decline a ‘Code Red' moment for the firm. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In 2 Kings 19, King Sennacherib of Assyria offers a juiced-up diatribe about his own accomplishments. And then the Lord speaks up and gets to work.Alex, Jim, and Sam discuss 2 Kings 19.

In this week's episode, Robert Morris LEAPS ahead of Philip in last name assholery, we learn from a SECRET Vatican document that the future is actually now, and we'll finally get to the first book of the Bible named after a toilet. --- To make a per episode donation at Patreon.com, click here: http://www.patreon.com/ScathingAtheist To buy our book, click here: https://www.amazon.com/Outbreak-Crisis-Religion-Ruined-Pandemic/dp/B08L2HSVS8/ If you see a news story you think we might be interested in, you can send it here: scathingnews@gmail.com To check out our sister show, The Skepticrat, click here: https://audioboom.com/channel/the-skepticrat To check out our sister show's hot friend, God Awful Movies, click here: https://audioboom.com/channel/god-awful-movies To check out our half-sister show, Citation Needed, click here: http://citationpod.com/ To check out our sister show's sister show, D and D minus, click here: https://danddminus.libsyn.com/ Report instances of harassment or abuse connected to this show to the Creator Accountability Network here: https://creatoraccountabilitynetwork.org/ --- Guest Links: Check Eli out on the “Bring Me The Axe!” podcast here: https://open.spotify.com/show/143VD2m2wUwWe90MA7j9NZ Learn more about Noah's talk for Skeptics in the Pub Online here: https://sitp.online/show/god-awful-gaming-noah-lugeons/ --- Headlines: RFK Jr's plan for bird flu (from the Diatribe): https://www.nytimes.com/2025/03/18/health/kennedy-bird-flu.html Megachurch founder and Trump “spiritual advisor” Robert Morris indicted for child sex abuse: https://www.friendlyatheist.com/p/megachurch-founder-robert-morris Peter Popoff's "Miracle Spring Water" scam costs religious TV network £150,000: https://www.friendlyatheist.com/p/peter-popoffs-miracle-spring-water Crazy Christian Post article about the conclusion of the DOJ investigation of the SBC: https://www.christianpost.com/news/doj-ends-investigation-of-sbc.html 900-year-old Vatican doomsday prophecy resurfaces amid Pope Francis' illness: https://www.euronews.com/culture/2025/03/14/900-year-old-vatican-doomsday-prophecy-resurfaces-amid-pope-francis-illness https://en.wikipedia.org/wiki/Prophecy_of_the_Popes --- This Week in Misogyny: Texas arrests midwife for providing abortions: https://www.bbc.com/news/articles/c74kr8vp4w0o Christian misogynists can't get women to show up at their singles events: https://www.wonkette.com/p/ladies-now-is-your-chance-to-meet

"If I write a book, will they tell me when it comes out?" - Marge Simpson Learn all about the publishing world as we discuss an episode that both lampoons and harpoons the world of bodice-ripping romance novels. Our guest: TheRealJims Support this podcast and get over 200 ad-free bonus episodes by visiting Patreon.com/TalkingSimpsons and becoming a patron! And please follow the official Twitter, @TalkSimpsonsPod, not to mention Bluesky and Instagram!

Drew has a lot to catch us up on with his beloved United as action on the pitch plus the activity off the pitch makes for a lot of heavy thinking...

Dr. Darrin Wright,FBCW,FBC Wheeling,Romans Sermon, Romans,Paul's Diatribe ,Romans 3,

It took a new manager for Drew to return with another diatribe!But, it's just in time after the international break comes to a close!It's a new coach, some tractors, and a new outlook!

Here's the point. It's Election Day. Our podcast is “With People Not At People” So to celebrate “conversations” in a season of hostility, hate, arrogant diatribes, and political commercials we want you to tell us what you want to talk about. We aren't going to tell you … You tell us.

Reunited does it feel so good? Aaron and Devantae will be the judge of that. Jerry is going off! Why does this time feel completely different in Dallas? And, a sudden switch in Steeltown. Is Pittsburgh really about to let Russ cook?  Learn more about your ad choices. Visit podcastchoices.com/adchoices

Jeffrey Lichtman is a prominent criminal defense attorney based in New York City. Known for his aggressive defense tactics and high-profile clients, Lichtman has earned a reputation as one of the most formidable defense lawyers in the United States.Lichtman graduated from Georgetown University Law Center and began his legal career as a prosecutor in the Manhattan District Attorney's Office. After gaining experience as a prosecutor, he transitioned to criminal defense work, where he quickly made a name for himself handling complex and high-stakes cases.Throughout his career, Lichtman has represented a diverse array of clients, including accused mobsters, drug traffickers, white-collar criminals, and individuals facing charges related to organized crime. He is known for his tenacious advocacy on behalf of his clients and his willingness to challenge the government at every turn.Lichtman gained widespread recognition for his role as part of the defense team for Joaquín "El Chapo" Guzmán, one of the most notorious drug lords in history. He played a key role in Guzmán's defense during his highly publicized trial in 2019, employing a vigorous defense strategy that included attacking the credibility of government witnesses and challenging the prosecution's evidence.In addition to his work as a defense attorney, Lichtman is also a frequent commentator on legal issues, often appearing as a legal analyst on television news programs to provide insights into high-profile criminal cases.Overall, Jeffrey Lichtman is a highly respected and experienced attorney who has earned a reputation for his zealous advocacy and formidable courtroom skills in the field of criminal defense.It should come as no shock to anyone out there that Diddy and his son would bring on high powered legal help, and hiring Lichtman certainly qualifies as that.    Lichtman, who is representing Diddy's son Justin, had a few things to say about the investigation and the raid and in this episode, we dive into his commentary and break it down. (commercial at 11:27)to contact me:bobbycapucci@protonmail.comsource:'Diddy' probe: Son's lawyer slams feds for 'dirtying' jury pool, leaks | Fox NewsBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-epstein-chronicles--5003294/support.

For this week's 3D, Drew looks at his beloved United and sees who may be gone, who may be staying, and the early morning match with Brighton on the board...

THE DOOMED AND STONED SHOW ~Season 10, Episode 10~ It's time to get our Summer Doom Charts recap on, beginning with a review of June's chart, (published in July at DoomCharts.com). We'll be recording our recap of July's chart (out Friday) by mid-month. There's a lot of fantastic new music to discover in this episode, hosted by Billy Goate (Editor in Chief, DoomedandStoned.com), John Gist (Vegas Rock Revolution), and Bucky Brown (The Ripple Effect) -- all long-time voting members of the Doom Charts! If you dig what you're doing, become a monthly 'High on Fiver' patron at https://patreon.com/doomedandstoned PLAYLIST: Summer Doom Charts Countdown Part I: June 2024 INTRO (00:00) 1. Wytch Pycnyck (#36) - "Columbo no. 5" (00:31) HOST SEGMENT I (03:11) 2. Black On High (#37) - "Leave You" (28:03) 3. Oh Hiroshima (#40) - "Rite of Passage" (31:03) 4. Stone Nomads (#15) - "Them Tempter" (Trouble cover) (38:19) HOST SEGMENT II (44:43) 5. Shadow Witch (#14) - "Nobody" (1:01:29) 6. Redwood (#11) - "Void Rider" (1:05:31) 7. Bus The Unknown Secretary (#19) - "Under My Skin" (1:11:41) HOST SEGMENT III (1:16:44) 8. Birdstone (#10) - "Cinnamon Creek" (1:29:56) 9. Wyndrider (#9) - "Motorcycle Witches" (1:34:56) 10. Stonekind (#8) - "Dune" (1:40:23) HOST SEGMENT IV (1:45:20) 11. Void Commander (#7) - "Dyke Blues" (2:03:02) 12. REZN (#6) - "Chasm" (2:06:24) 13. Rifflord (#5) - "LM308" (2:11:00) HOST SEGMENT V (2:15:21) 14. Horseburner (#4) - "The Gift" (2:48:57) 15. Sons of Arrakis (#3) - "Beyond the Screen of Illusion" (2:54:20) 16. Fu Manchu (#2) - "Hands of the Zodiac" (2:58:11) 17. Greenleaf (#1) - "Breathe, Breathe Out" (3:01:57) OUTRO (3:07:31) Bonus Tracks: 18. The Ghost Next Door (#39) - "Diatribe" (3:08:39) 19. Amon Acid (#31) - "Crawling Chaos" (3:13:40) 20. Black Rainbows (#27) - "Dogs of War" (3:17:30) 21. WeeDevil (#14) - "Serpent's Gaze" (3:23:06) Theme Song: Dylan Tucker Thumbnail Art: Redwood

Plus some new faces and chases for more reinforcements...Drewski looks at his beloved United and preps for the west coast roadie!

Drew is back after digesting possible ins and outs with his beloved United...We'll see what he thinks about the possible futures and players in discussion... 

You have to meet PSR pretty soon in the Prem, so Drew looks at his beloved United and what decisions they have to make progress for the 2024-25 season...

Merriam-Webster's Word of the Day for June 23, 2024 is: polemic • puh-LEM-ik • noun A polemic is a strong written or spoken attack against someone else's opinions, beliefs, practices, etc. // Her book is a fierce polemic against societal inequalities. See the entry > Examples: “That winter of 1774-1775 could be considered the nadir of the entire American patriot movement. After the closing of the First Continental Congress, North Americans ‘turned upon one another as never before.' The colonists had never had a single view of Britain or how to respond to the measures it was trying to impose on the American colonies. … Strong polemics against further resistance to the British government spouted from printing presses across the colonies.” — Nathan Perl-Rosenthal, The Age of Revolutions, 2024 Did you know? Diatribe, jeremiad, philippic … the English language sure has a lot of formal words for the things we say or write when we are—to use a decidedly less formal term—big mad. We will refrain from going on a tirade about it, however, especially since it's good to have options with subtle differences in tone and meaning. Polemic, which traces back ultimately to the Greek word for war, polemos, is the word you want to refer specifically to an aggressive attack on someone's ideas or principles. Someone who is cheesed off because they don't like cheese, for example, wouldn't write a polemic about it. A turophile upset about the gustatory philosophy behind their local cheesemonger's recent offerings just might.

With ten Hag IN, Drew looks at the questions of outbounds and possible imports going forward for his beloved United... 

It's a quick one, but Drew has his first thoughts before his longer 3D on the weekend about the news out of Manchester...

Drew renders his decision on his managerial search for his beloved United and anything else on his mind for this week...

This was before the alleged breaking news involving ETH Friday morningBut Drew looks at the awards given to his beloved United and what they face going forward with one match left in the 2024 season...

It's Championship Sunday in the Prem this weekend...Drew looks at the end of the season through the prism of his beloved United

Drew goes down a different road this week...There's a lot of talk swirling around his beloved United, so Drew addresses it head-on

So, what's on Drew's mind this time as the run-in gets smaller and smaller...???Here's the 3D on his beloved United...

Drew has some things to get off his chest (more than normal, maybe...?) on his beloved United plaus he looks at the run-in for a few teams in and around Manchester United in the table...